Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 05:16 | 2024-12-23 | N/A | N/A | MSD CAPITAL L P | 10% owner | Other | BUY | $24.81 | 221,479 | $5,494,894 | 277,610 | +394.6% |
| 2025-03-04 02:56 | 2025-02-27 | FLWS | 1 800 FLOWERS COM INC | Fund 1 Investments, LLC | 10% owner | Retail-Retail Stores, NEC | BUY | $6.89 | 335,500 | $2,310,857 | 7,642,969 | +4.6% |
| 2025-03-01 00:05 | 2025-02-26 | CLRO | CLEARONE INC | BAGLEY EDWARD D | 10% owner | Telephone & Telegraph Apparatus | BUY | $0.50 | 2,000,000 | $1,000,000 | 12,590,528 | +18.9% |
| 2025-03-01 00:57 | 2025-02-26 | ACDC | ProFrac Holding Corp. | Wilks Farris | 10% owner | Oil & Gas Field Services, NEC | BUY | $6.93 | 338,756 | $2,347,579 | 1,316,534 | +34.6% |
| 2025-03-01 00:04 | 2025-02-26 | ADVM | Adverum Biotechnologies, Inc. | Leonard Braden Michael | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $4.27 | 336,756 | $1,439,093 | 2,604,820 | +14.8% |
| 2025-02-28 04:32 | 2025-02-26 | AENT | Alliance Entertainment Holding Corp. | Walker Jeffrey Clinton | Director, Officer, 10% owner - Chief Executive Officer | Wholesale-Durable Goods, NEC | BUY | $38,891.90 | 69,184 | $2,690,697,071 | 23,005,262 | +0.3% |
| 2025-02-28 00:23 | 2025-02-26 | ACDC | ProFrac Holding Corp. | Wilks Matthew | Director, Officer - Executive Chairman | Oil & Gas Field Services, NEC | BUY | $6.93 | 288,756 | $2,001,079 | 288,756 | +100.0% |
| 2025-02-28 02:42 | 2025-02-10 | ORKA | Oruka Therapeutics, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $11.45 | 122,882 | $1,407,368 | 4,148,428 | +3.1% |
| 2025-02-28 00:18 | 2025-02-25 | PBF | PBF Energy Inc. | Control Empresarial de Capitales S.A. de C.V. | 10% owner, Other | Petroleum Refining | BUY | $22.23 | 263,000 | $5,846,806 | 29,974,998 | +0.9% |
| 2025-02-28 00:30 | 2025-02-27 | AKAM | Akamai Technologies Inc. | LEIGHTON F THOMSON | Director, Officer - Chief Executive Officer | Services-Business Services, NEC | BUY | $79.58 | 37,670 | $2,997,933 | 137,342 | +37.8% |
| 2025-02-27 03:30 | 2025-02-24 | N/A | N/A | Apollo Principal Holdings B, L.P. | 10% owner | Other | BUY | $27.33 | 512,319 | $13,999,985 | 5,485,995 | +10.3% |
| 2025-02-27 01:21 | 2025-02-24 | TBRG | TruBridge, Inc. | L6 Holdings Inc. | 10% owner | Services-Computer Programming Services | BUY | $28.14 | 117,609 | $3,309,411 | 1,828,393 | +6.9% |
| 2025-02-27 01:11 | 2025-02-24 | FLWS | 1 800 FLOWERS COM INC | Fund 1 Investments, LLC | 10% owner | Retail-Retail Stores, NEC | BUY | $7.48 | 222,500 | $1,663,566 | 7,307,469 | +3.1% |
| 2025-02-27 01:24 | 2025-02-24 | AMKR | Amkor Technology Inc. | Sujoda Management, LLC | Other | Semiconductors & Related Devices | BUY | $21.85 | 869,565 | $18,999,995 | 3,347,890 | +35.1% |
| 2025-02-27 01:27 | 2025-02-24 | AMKR | Amkor Technology Inc. | SUJODA Investments, LP | Other | Semiconductors & Related Devices | BUY | $21.85 | 869,565 | $18,999,995 | 3,347,890 | +35.1% |
| 2025-02-27 01:18 | 2025-02-24 | AMKR | Amkor Technology Inc. | KIM JOHN T | 10% owner, Other | Semiconductors & Related Devices | BUY | $21.85 | 869,565 | $18,999,995 | 3,347,890 | +35.1% |
| 2025-02-27 01:31 | 2025-02-24 | AMKR | Amkor Technology Inc. | KIM DAVID D | Other | Semiconductors & Related Devices | BUY | $21.85 | 869,565 | $18,999,995 | 3,347,890 | +35.1% |
| 2025-02-27 01:16 | 2025-02-24 | AMKR | Amkor Technology Inc. | KIM SUSAN Y | Director, 10% owner, Other | Semiconductors & Related Devices | BUY | $21.85 | 869,565 | $18,999,995 | 3,347,890 | +35.1% |
| 2025-02-25 14:27 | 2025-02-24 | MSCI | MSCI Inc. | Fernandez Henry A | Director, Officer - Chairman and CEO | Services-Business Services, NEC | BUY | $574.51 | 5,300 | $3,044,902 | 1,269,951 | +0.4% |
| 2025-02-25 21:18 | 2025-02-21 | N/A | N/A | Abu Dhabi Investment Authority | 10% owner | Other | BUY | $1,824.00 | 8,224 | $15,000,000 | 93,472 | +9.6% |
| 2025-02-26 01:35 | 2025-02-24 | LARK | LANDMARK BANCORP INC | Kohlrus Mark J. | Director | National Commercial Banks | BUY | $12,284.25 | 400 | $4,913,698 | 1,200 | +50.0% |
| 2025-02-26 00:41 | 2025-02-24 | ZBRA | ZEBRA TECHNOLOGIES CORP | GUSTAFSSON ANDERS | Director | General Industrial Machinery & Equipment | BUY | $309.96 | 3,227 | $1,000,243 | 204,903 | +1.6% |
| 2025-02-26 05:17 | 2025-02-24 | PDFS | PDF SOLUTIONS INC | KIBARIAN JOHN KACHIG | Director, Officer - PRESIDENT AND CEO | Services-Prepackaged Software | BUY | $22.58 | 50,000 | $1,129,205 | 2,522,756 | +2.0% |
| 2025-02-25 00:15 | 2025-02-20 | SEPN | Septerna, Inc. | Third Rock Ventures VI, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $5.93 | 1,040,342 | $6,167,355 | 4,192,798 | +33.0% |
| 2025-02-25 01:00 | 2025-02-20 | SSII | SS Innovations International, Inc. | MOLL FREDERIC H | Director, 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $1.37 | 3,645,224 | $5,001,247 | 10,060,813 | +56.8% |
| 2025-02-22 04:02 | 2025-02-20 | CMPO | GPGI, Inc. | Resolute Compo Holdings LLC | Director, 10% owner | Finance Services | BUY | $16.57 | 233,070 | $3,861,970 | 879,963 | +36.0% |
| 2025-02-22 04:00 | 2025-02-20 | CMPO | GPGI, Inc. | Cote John D. | Director, 10% owner | Finance Services | BUY | $16.57 | 233,070 | $3,861,970 | 879,963 | +36.0% |
| 2025-02-22 04:01 | 2025-02-20 | CMPO | GPGI, Inc. | Knott Thomas R. | Director, 10% owner | Finance Services | BUY | $16.57 | 233,070 | $3,861,970 | 879,963 | +36.0% |
| 2025-02-22 01:48 | 2025-02-19 | SLDB | Solid Biosciences Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $4.03 | 1,000,000 | $4,030,000 | 5,034,582 | +24.8% |
| 2025-02-22 01:19 | 2025-02-19 | ALLE | Allegion plc | SENGSTACK GREGG C | Director | Services-Detective, Guard & Armored Car Services | BUY | $125.24 | 8,000 | $1,001,920 | 8,000 | +100.0% |
| 2025-02-22 01:37 | 2025-02-19 | TBRG | TruBridge, Inc. | Pinetree Capital Ltd. | 10% owner | Services-Computer Programming Services | BUY | $28.17 | 124,858 | $3,517,150 | 1,710,784 | +7.9% |
| 2025-02-22 00:17 | 2025-02-19 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $4.03 | 5,000,000 | $20,150,000 | 11,833,539 | +73.2% |
| 2025-02-22 00:41 | 2025-02-20 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FOSTER JAMES C | Director, Officer - Chairman, President and CEO | Services-Commercial Physical & Biological Research | BUY | $165.01 | 6,075 | $1,002,436 | 183,639 | +3.4% |
| 2025-02-22 01:29 | 2025-02-19 | FLWS | 1 800 FLOWERS COM INC | Fund 1 Investments, LLC | 10% owner | Retail-Retail Stores, NEC | BUY | $8.01 | 684,000 | $5,479,114 | 7,084,969 | +10.7% |
| 2025-02-21 00:13 | 2024-11-08 | VLY | VALLEY NATIONAL BANCORP | BANK LEUMI LE ISRAEL BM | 10% owner | National Commercial Banks | BUY | $9.35 | 1,000,000 | $9,350,000 | 72,861,862 | +1.4% |
| 2025-02-21 03:42 | 2025-02-18 | RCUS | Arcus Biosciences, Inc. | GILEAD SCIENCES, INC. | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 1,363,636 | $14,999,996 | 31,424,760 | +4.5% |
| 2025-02-20 02:00 | 2025-02-14 | ATAI | Atai Beckley N.V. | Apeiron Investment Group Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $2.10 | 10,835,718 | $22,755,008 | 40,555,215 | +36.5% |
| 2025-02-19 17:32 | 2025-02-14 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $18.01 | 1,110,670 | $20,000,054 | 46,579,096 | +2.4% |
| 2025-02-19 17:23 | 2025-02-14 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $18.01 | 333,201 | $6,000,016 | 37,613,321 | +0.9% |
| 2025-02-20 00:02 | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Cormorant Asset Management, LP | Other | Pharmaceutical Preparations | BUY | $16.00 | 187,500 | $3,000,000 | 987,689 | +23.4% |
| 2025-02-19 20:35 | 2025-02-18 | CVS | CVS HEALTH Corp | Mahoney Michael F | Director | Retail-Drug Stores and Proprietary Stores | BUY | $66.70 | 30,000 | $2,001,000 | 39,356 | +320.6% |
| 2025-02-20 05:16 | 2024-06-25 | RZLT | Rezolute, Inc. | Kim Young-Jin | Director | Pharmaceutical Preparations | BUY | $4.00 | 1,250,000 | $5,000,000 | 7,192,617 | +21.0% |
| 2025-02-20 01:44 | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Decheng Capital Global Life Sciences Fund IV, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 1,250,000 | $20,000,000 | 958,412 | +100.0% |
| 2025-02-20 00:16 | 2025-02-18 | SLDB | Solid Biosciences Inc. | Adage Capital Management, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $7.56 | 252,545 | $1,909,240 | 4,248,084 | +6.3% |
| 2025-02-20 01:56 | 2025-02-14 | MBX | MBX Biosciences, Inc. | GORDON CARL L | Director, 10% owner | Pharmaceutical Preparations | BUY | $10.60 | 190,672 | $2,020,761 | 747,887 | +34.2% |
| 2025-02-20 00:23 | 2025-02-18 | BRKR | BRUKER CORP | LAUKIEN FRANK H | Director, Officer, 10% owner - PRESIDENT & CEO | Laboratory Analytical Instruments | BUY | $50.92 | 20,000 | $1,018,330 | 38,459,563 | +0.1% |
| 2025-02-20 01:52 | 2025-02-14 | MBX | MBX Biosciences, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $10.60 | 190,672 | $2,020,761 | 747,887 | +34.2% |
| 2025-02-18 20:44 | 2025-02-13 | N/A | N/A | UAW Chrysler Retirees Medical Benefits Plan | 10% owner | Other | BUY | $5,259.00 | 4,706 | $24,750,011 | 28,183 | +20.0% |
| 2025-02-18 14:08 | 2025-02-14 | SSII | SS Innovations International, Inc. | Adams Timothy P. | Director | Surgical & Medical Instruments & Apparatus | BUY | $1.37 | 1,250,000 | $1,715,000 | 5,031,902 | +33.1% |
| 2025-02-19 02:09 | 2025-02-13 | MRP | Millrose Properties, Inc. | Richman Darren | Officer - See Remarks | Real Estate | BUY | $22.65 | 265,000 | $6,001,508 | 44,000 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.